title: Maintenance therapy for first-line metastatic colorectal cancer: activity and sustainability.
authors.affiliation: Seeley G. Mudd Building, 10 Bryan Searle Drive, Box 3052, Durham, North Carolina 27710, USA.
authors.forename: John H
authors.initials: JH
authors.lastname: Strickler
authors.forename: Herbert I
authors.initials: HI
authors.lastname: Hurwitz
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab